Galantamine in Alzheimer's disease.
Galantamine is a cholinesterase inhibitor with a dual mechanism of action. It is a reversible inhibitor of acetylcholine esterase and enhances the intrinsic action of acetylcholine on nicotinic receptors, leading to increased cholinergic neurotransmission in the CNS. Galantamine has a large volume c...
Hlavní autoři: | Razay, G, Wilcock, G |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2008
|
Podobné jednotky
-
The beneficial effects of galantamine on caregiver time in Alzheimer's disease
Autor: Sano, M, a další
Vydáno: (2003) -
The effects of galantamine treatment on caregiver time in Alzheimer's disease.
Autor: Sano, M, a další
Vydáno: (2003) -
Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.
Autor: Wilcock, G, a další
Vydáno: (2000) -
Hyperinsulinaemia and Alzheimer's disease.
Autor: Razay, G, a další
Vydáno: (1994) -
A long-term comparison of galantamine and donepezil in the treatment of Alzheimer's disease.
Autor: Wilcock, G, a další
Vydáno: (2003)